ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PXYN Praxsyn Corporation (CE)

0.000001
0.00 (0.00%)
11 Feb 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Praxsyn Corporation (CE) USOTC:PXYN OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.00 00:00:00

Current Report Filing (8-k)

10/07/2018 1:39pm

Edgar (US Regulatory)


 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 2, 2018

 

PRAXSYN CORPORATION

(Exact name of Registrant as specified in its charter)

 

Nevada   333-130446   20-3191557
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

61 Spectrum Blvd., Las Vegas, NV 89101

 

(Address of principal executive offices, including zip code)

 

(949) 777-6112

 

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

[  ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

 

 

 

 
 

 

Item 5.02 Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

Effective July 2, 2018, Ms. Kimberly A. Brooks resigned as General Counsel and Secretary of Praxsyn Corporation (the “Company”). On the same date, Ms. Brooks also resigned from any and all positions she has held with the Company and its subsidiaries, including but not limited to resigning as Secretary of Mesa Pharmacy, Inc., Nevada Health Rx, Inc., and Prax Direct, Inc.

 

The Company currently owes Ms. Brooks her unpaid salary and benefits from September 16, 2017 thru July 2, 2018. In addition, Ms. Brooks and has 11 unpaid promissory notes for past due wages from 2016, which are accruing interest at 18% per annum, with a total principal amount due of $49,437.66.

 

Ms. Brooks resignation was not due to any disagreement or matter relating to the Company’s operations, policies or practices, but instead is to pursue other business opportunities.

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  By: /s/ Greg Sundem
    Greg Sundem, Chief Executive Officer

 

Dated: July 9, 2018

 

 
 

 

1 Year Praxsyn (CE) Chart

1 Year Praxsyn (CE) Chart

1 Month Praxsyn (CE) Chart

1 Month Praxsyn (CE) Chart

Your Recent History

Delayed Upgrade Clock